Skip to content

Evaluation of the effects of PanRetinal Photocoagulation in Diabetic Retinopathy

Evaluation Of The Effects Of Pan Retinal Photocoagulation In Diabetic Retinopathy Using Optical Coherence Tomography Angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030217
Enrollment
30
Registered
2021-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H352- Other non-diabetic proliferative retinopathy

Interventions

Intervention1: Panretinal Photocoagulation: All the patients included in the study will be treated with Panretinal Photocoagulation, performed at two to three consecutive sessions with adherence to th

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects in the age range of 40-70 years, undergoing full panretinal photocoagulation , for very severe non-proliferative diabetic retinopathy and early proliferative diabetic retinopathy Subjects having best corrected visual acuity of at least 6/60

Exclusion criteria

Exclusion criteria: Subjects having other significant ocular or systemic diseases like glaucoma, media opacity, optic atrophy, retinal disease, central nervous system disease or tumours Subjects with history of previous treatment for diabetic retinopathy including anti-VEGF and laser

Design outcomes

Primary

MeasureTime frame
Changes in Optical Coherence Tomography Angiography parameters ( Foveal Avascular Zone)Timepoint: 3 months

Secondary

MeasureTime frame
1. Changes in Optical Coherence Tomography Angiography parameters ( Central Macular Thickness) 2. Changes in Optical Coherence Tomography parameters (Retinal Nerve Fibre Layer)Timepoint: 3 months

Countries

India

Contacts

Public ContactPunita Kumari Sodhi

Maulana Azad Medical College

sodhipunita@gmail.com9891373756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026